BjcuL is a C-type lectin with specificity for the binding of β-D-galactose units isolated from Bothrops jararacussu venom. It triggers cellular infiltration in post capillary venules, increases edema and vascular permeability in murine models, contributes to in vitro neutrophil activation and modulates macrophage functional activation towards an M1 state. The purpose of this study was to investigate the effect of BjcuL on human peripheral blood mononuclear cells (PBMCs) activation with a focus on PBMCs proliferation and inflammatory mediators release. Results showed that BjcuL is not toxic to PBMCs, that BjcuL inhibits PBMCs proliferation and that it stimulates PBMCs to produce superoxide anion and hydrogen peroxide, primarily via lymphocyte stimulation, but does not stimulate the production of nitric oxide and PGE 2 . These results demonstrate that BjcuL has an immunomodulatory effect on PBMCs. Further studies are needed to confirm the immunomodulatory effect of BjcuL, to elucidate the molecular mechanisms of action responsible for its effects and to determine its potential application as an immunopharmacological and biotechnological tool.
Introduction
Bothrops jararacussu is one of Brazil's most dreaded snakes. This important pit-viper may grow to a length of 2.2 m and its venom glands can deliver up to 1000 mg (dry weight) of highly-lethal venom in a single bite. It is responsible for 0.8% to 10% of serious snakebites in São Paulo State, Brazil (Milani Júnior et al., 1997) . Bothrops jararacussu venom is composed primarily of enzymatic proteins such as phospholipases A 2 (PLA 2 ), serine and metalloproteases, and non-enzymatic lectin proteins.
Snake venom lectins comprise a class of toxins that bind, non-covalently and with high specificity, to terminal galactoside residues of glycans. The recognition of specific glycans by lectins is an event that plays a key role in a variety of biological phenomena (Kishore et al., 1997) .
The lectin BjcuL was isolated from Bothrops jararacussu venom. This lectin is a C-type lectin with specificity for the binding of β-D-galactose units (de Carvalho et al., 2002) .
BjcuL has been shown to bind to lactose moieties and induce agglutination of erythrocytes. The literature shows that BjcuL weakly adheres to MDAMB-435, a human metastatic breast cancer cell line, and to OVCAR-5, a human ovarian carcinoma cell line (de Carvalho et al., 2001) . Moreover, BjcuL inhibits growth in several cancer cell lines (Damasio et al., 2014; de Carvalho et al., 2001; Nolte et al., 2012; Pereira-Bittencourt et al., 1999) . However, BjcuL does not inhibit adhesion of these cancer cells to the extracellular matrix proteins fibronectin, laminin and type I collagen (de Carvalho et al., 2001) .
BjcuL triggers cellular infiltration in post capillary venules (ElifioEsposito et al., 2007) , increases edema and vascular permeability in murine models (Panunto et al., 2006) and contributes to in vitro neutrophil activation (Elifio-Esposito et al., 2011) . The literature on the inflammatory effects of BjcuL indicates that BjcuL modulates macrophage functional activation towards an M1 state (Dias-Netipanvi et al., 2016) ; the aim of this study was to investigate the effect of BjcuL on human PBMCs activation with a focus on PBMCs proliferation and inflammatory mediators release.
Material and methods

Chemicals and reagents
MTT, RPMI-1640, L-glutamine, gentamicin, lipopolysaccharide (LPS), concanavalin A (Con-A), phorbol myristate acetate (PMA), Histopaque 1077, DMSO, OPD (o-1,2-phenylenediamine dihydrochloride), horseradish peroxidase, nitroblue tetrazolium (NBT), carboxyfluorescein diacetate succinimidyl ester (CFDA-SE) and anti-iNOS antibody were purchased from Sigma (MO, USA). Cell Viability Kit, PE anti-human CD14, PE anti-human CD4, PE anti-human CD8 and PerCP anti-human CD3 were purchased from BD Pharmingen (CA, USA). 2′,7′-dichlorodihydrofluorescein diacetate (DCFDA) was purchased from Molecular Probes (OR, USA). PGE 2 specific enzymatic immunoassay (EIA), anti-COX-1 and anti-COX-2 antibodies were purchased from Cayman Chemicals (MI, USA). Fetal bovine serum (FBS) was obtained from Cultilab (São Paulo, Brazil) . All salts and reagents were obtained from Merck (Darmstadt, Germany).
Ethical statement
This study was approved by the Brazilian Institutional Review Board of the Centre for Research in Tropical Medicine (CEPEM-RO), under protocol numbered 067/08. All subjects were adult volunteers and all signed a Statement of Informed Consent.
Venom
The Bothrops jararacussu snake venom was provided by Serpentário Proteínas Bioativas (Batatais -SP) and maintained refrigerated (8°C) in the Bank of Amazon Venoms at the Center of Biomolecular Studies Applied to Health, CEBIO-UNIR-FIOCRUZ-RO, (authorization: CGEN/CNPq 010627/2011-1 and IBAMA 27131-1).
Affinity column preparation
Initially, 20 mL of Sepharose 6B resin was transferred to a Buchner funnel and washed with 30 mL of distilled water. After the complete elimination of water, the resin was suspended in 15 mL of NaOH 1 M containing 30 mg of sodium borohydrate. The contents were transferred to a plastic beaker and 5 mL of bisepoxi was added. The activation was processed for 5 h at room temperature under gentle agitation. The activated resin was transferred to a Buchner funnel and washed with 300 mL of distilled water. Lactose coupling proceeded for 24 h at room temperature in bicarbonate buffer 0.5 M (pH 10.0), using an equal volume of ligand solution and activated resin. After lactose coupling, the remaining epoxi groups were blocked with β-mercaptoethanol for 2 h at room temperature. The coupled resin was washed with 200 mL of sodium bicarbonate 0.5 M, 50 mL of sodium acetate 0.2 M (pH 4.0), and 50 mL of saline, respectively. The coupled resin (Sepharose 6B-CL-lactose) was maintained at 4°C until use.
Purification of a lectin from Bothrops jararacussu venom
Bothrops jararacussu venom (100 mg) was dissolved in CaTBS buffer (0.02 M Tris, 0.15 M NaCl and 0.01 CaCl 2 ) (pH 7.4), and clarified by ultracentrifugation at 3500 × g for 5 min. The supernatant was applied and fractionated on a column (3 cm × 1 cm) of Sepharose 6B-CL-lactose which was pre-equilibrated with the same buffer used to dissolve the venom. The resin was washed until the optical density measured 280 nm returned to basal levels. The retained material was eluted using 0.1 M lactose in CaTBS. The resin fraction was filtered using Sephadex G-25 to remove the lactose. The purity of the eluted protein was evaluated with RP-HPLC using a C18 column (Discovery 0.45 cm × 25 cm; Supelco -USA) under a linear gradient 0-60% of acetonitrile in 0.1% trifluoroacetic acid (v/v). All chromatographic steps were done using an Akta Purifier 10 system (GE Lifescience Healthcare -USA). SDS-PAGE 12.5%, performed as described by Laemmli (1970) , confirmed the apparent weight and molecular homogeneity of the resin fraction. The protein concentration was estimated using Bradford reagent with a solution of BSA as the protein standard.
Molecular mass determination
Molecular mass was determined by mass spectrometry performed with MALDI equipment (matrix-assisted laser desorption ionization) using TOF analyzers (AXIMA TOF 2 Shimadzu Biotech) and a saturated solution of sinapinic acid as the ionization matrix. The sample was cocrystallized with the ionization matrix (1:3 ratio, respectively) and analyzed in linear mode.
Hemagglutinanting activity
Hemagglutinanting activity was performed using a microagglut ination technique to determine the presence of BjcuL. This technique used human erythrocytes previously collected with heparin (50 U/mL), and microtiter V-well plates. Each well contained 50 μL of 3% erythrocytes suspension and CaTBS with 50 μL samples in the same buffer. The negative control contained 50 μL of cell suspension and 50 μL of CaTBS. Following the addition of erythrocytes, the plates were shaken briefly and incubated at room temperature. The agglutination was monitored visually after 2 h.
Isolation of human peripheral blood mononuclear cells (PBMC)
Blood was donated by healthy volunteers who had not used medication in the last 48 h. Blood was collected in vacuum tubes containing heparin, and diluted in phosphate buffered saline (PBS -14 mM NaCl, 2 mM NaH 2 PO 4 ·H 2 O, 7 mM Na 2 HPO 4 ·12H 2 O) (pH 7.4). PBMCs were isolated by density gradient method-according to Lacouth-Silva et al. (2015) -using Histopaque 10,771 (Sigma; MO, USA), as per the manufacturer's instructions. Briefly, the blood diluted in PBS was layered on Histopaque at a 1:1 ratio and subjected to centrifugation at 400 ×g for 30 min. The white layer representing PBMCs was gently aspirated out and aseptically transferred into sterile centrifuge tubes. After centrifugation, the cell suspension containing the PBMCs was washed 3 times with PBS and cultured in sterile RPMI assay medium [RPMI-1640 medium supplemented with 100 μg/mL of gentamicin, 2 mM of L-glutamine and 10% of fetal bovine serum (FBS)]. Aliquots of the isolated PBMCs were used to determine the total number of cells in a Neubauer's chamber following cell staining (1:20, v/v) with Turk solution (0.2% violet crystal in 30% acetic acid). The purity of the isolated cell populations was determined by Panotic staining of cytospin preparations and by flow cytometry analysis (FACscan). The mean purity was 99% for PBMC preparation. The number of cells was adjusted to 10 5 or 10 6 , relative to the amount of cells necessary for each experiment.
Cell viability assay by MTT reduction
The cytotoxicity of BjcuL on PBMCs was determined by an MTT assay (Reilly et al., 1998; Lacouth-Silva et al., 2015) , which made it possible to analyze the capacity of living cells to reduce the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT, Sigma; MO, USA) to a purple formazan product. Cells were plated in 96-well plates (2 × 10 5 /well) and maintained in RPMI assay medium. PBMCs were incubated with RPMI (negative control) or BjcuL (5 and 10 μg/mL diluted in RPMI; experimental group) for 96 h at 37°C, under an atmosphere of 5% CO 2 . After incubation, the plate was centrifuged at 400 ×g for 5 min and the supernatant was replaced by fresh RPMI containing MTT (0.5 μg/mL). Four hours later, the plates were washed three times with PBS. The formazan crystals were dissolved in 100 μL DMSO over 90 min and were evaluated by spectrophotometer at 540 nm (Bio-Tek Synergy HT Multi-Detection, Winooski, VT). The results were expressed by optical density relative to the control. 
Cell proliferation assay by MTT reduction
Cell proliferation was tested using a 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay. PBMCs were freshly isolated and plated in 96-well flat bottom tissue culture plates at a concentration of 2 × 10 5 cells/well containing 200 μL of RPMI assay medium.
PBMCs were cultured with RPMI (negative control), Concanavalin A (5 μg/mL; positive control), or BjcuL (5 and 10 μg/mL; experimental group) for 96 h at 37°C, under an atmosphere of 5% CO 2 . After incubation, 10 μL of MTT solution (5 mg/mL in PBS) was added to each well. After 4 h, the plates were centrifuged at 400 ×g for 5 min and the supernatant was removed. After washing with PBS, the formazan crystals were dissolved with 100 μL of DMSO and the plates were kept on an orbital shaker for 90 min. The optical density (O.D.) was measured in a spectrophotometer at 570 nm (BioTek Synergy HT Multi-Detection, Winooski, VT). The results were expressed by optical density relative to the controls.
Cell proliferation assay by flow cytometry
Cell proliferation was tested using carboxyfluorescein diacetate succinimidyl ester (CFDA-SE). In brief, isolated PBMCs were stained with CFDA-SE and plated in 96-well flat bottom tissue culture plates at a concentration of 1 × 10 6 cells/well containing 100 μL of RPMI assay medium. After that, PBMCs were incubated with RPMI (negative control), Concanavalin A (5 μg/mL; positive control), or BjcuL (5 and 10 μg/mL; experimental group) for 72 h at 37°C, under an atmosphere of 5% CO 2 . After incubation, cell surface labeling was performed with monoclonal antibody PerCP anti-human CD3, PE anti-human CD14, PE anti-human CD4, and PE anti-human CD8 incubated for 30 min on ice and protected from light. PBMCs were washed with PBS to remove unbound antibodies. Acquisition and analysis was performed in FACScan.
Superoxide anion production assay
In this assay, the generation of superoxide was estimated by reducing nitroblue tetrazolium (NBT, Sigma; MO, USA), a yellow liposoluble compound that becomes insoluble and blue in its reduced form (Pontes et al., 2014) . In brief, 2 × 10 5 PBMCs/100 μL were incubated with 100 μL of RPMI containing 0.1% NBT (negative control), 100 μL of PMA containing 0.1% NBT (500 ng/mL; positive control), or BjcuL (5 and 10 μg/mL diluted in RPMI containing 0.1% NBT; experimental group) and incubated for 2 h at 37°C, in a humidified atmosphere of 5% CO 2 . At the end of the incubation period, the supernatant was removed and the cells were centrifuged at 800 ×g for 5 min. After washing with PBS, the reduced NBT deposited inside the cells was dissolved, first by adding 120 μL of 2 M KOH to solubilize the cell membranes, and then by adding 140 μL of DMSO to dissolve the blue formazan via gentle shaking for 10 min at room temperature. The dissolved NBT solution was then transferred to a 96-well plate and absorbance was measured on a spectrophotometer at 620 nm (Bio-Tek Synergy HT Multi-Detection, Winooski, VT). Data were expressed as absorbance.
Determination of hydrogen peroxide (H 2 O 2 ) production by human PBMCs
The technique used was described by Pick and Keisari (1980) , and adapted for microassay by Pick and Mizel (1981) , with modifications proposed by Russo et al. (1989) . In brief, PBMCs (2 × 10 5 /100 μL)
were resuspended in 1 mL of phenol red solution (140 mM NaCl, 10 mM potassium phosphate buffer (pH 7.0), 0.56 mM phenol red) containing 0.05 mg/mL of horseradish peroxidase. The cells were then incubated with RPMI (negative control) or BjcuL (5 and 10 μg/mL) for 3 h at 37°C, under a humidified atmosphere of 5% CO 2 . Cells were maintained simultaneously with and without stimulation by phorbol myristate acetate (PMA, 500 ng/mL). After incubation, the reaction was stopped by the addition of 1 N sodium hydroxide (10 mL). The absorbance was measured spectrophotometrically (Bio-Tek Synergy HT Multi-Detection, Winooski, VT), at 620 nm, against the blank which consisted of phenol red medium. The data generated were compared to a standard curve conducted for each test. The results were expressed in terms of mM of H 2 O 2 produced.
Measurement of intracellular ROS levels
A peroxide-sensitive fluorescent probe 2′,7′-dichlorodihydrofluoresce in diacetate (DCFDA) was used to measure intracellular levels of ROS. DCFDA is converted by intracellular esterases to 2′,7′-dichlorodihy drofluorescin, which is then oxidized by H 2 O 2 to the highly fluorescent 2′,7′-dichlorodihydrofluorescein (DCF). For this assay, 2 × 10 6 PBMCs were resuspended in RPMI without phenol red, and the cells were incubated with RPMI without phenol red (negative control), PMA (500 ng/ mL; positive control), or BjcuL (5 and 10 μg/mL). After 3 h of incubation, 100 μL of DCFDA, diluted with 10 μM of PBS, was added and incubated for 30 min at 37°C, under constant dark conditions (Nakajima et al., 2009) . After incubation, cell surface labeling was performed with monoclonal antibody PerCP anti-human CD3 or PE anti-human CD14, incubated for 30 min on ice and protected from light. PBMCs were washed with PBS to remove unbound antibodies. Acquisition and analysis was performed in FACScan.
Nitric oxide (NO) production assay
NO production by PBMC cultures, incubated with and without BjcuL, was determined in the supernatant. PBMCs, at a density of 2 × 10 5 / 250 μL in RPMI assay medium, were plated in 96-well plates and incubated with RPMI (negative control), LPS (1 μg/mL; positive control), or BjcuL (5 and 10 μg/mL; experimental group) for 96 h at 37°C, in a humidified atmosphere of 5% CO 2 . After incubation, the supernatants of the cells were transferred to a reading plate, and Griess reagent was added (in the ratio of 1:1, v/v) for the determination of nitrite (Ding and Nathan, 1988) . The absorbance was measured spectrophotometrically (Bio-Tek Synergy HT Multi-Detection, Winooski, VT), at 550 nm, and data were compared to a standard curve prepared with NaNO 2 (2.5 to 80 μM) and expressed in terms of μM nitrite released by 2 × 10 5 cells.
2.17. Determination of prostaglandin E 2 (PGE 2 ) production PGE 2 concentration was measured using an enzyme immunoassay kit from Cayman Chemical (MI, USA) (Pontes et al., 2016) . PBMCs (2 × 10 5 cells/mL) were suspended in RPMI assay medium and incubated in 96-well plates with RPMI (negative control), LPS (1 μg/mL; positive control), PMA (150 μg/mL; positive control), or BjcuL (5 and 10 μg/mL; experimental group) for 3 h at 37°C, in a humidified atmosphere of 5% CO 2 . Briefly, 100 μL aliquots of each sample were incubated with the eicosanoids conjugated with acetylcholinesterase and the specific rabbit antiserum in 96-well microtitration plates coated with antirabbit IgG mouse monoclonal antibody. After substrate addition, the sample absorbances were registered at 412 nm in a spectrophotometer (Bio-Tek Synergy HT Multi-Detection, Winooski, VT), and eicosanoids concentrations were estimated from standard curves expressed in terms of pg/mL of PGE 2 .
Immunoblotting
For this assay, 2 × 10 6 PBMC suspensions resuspended in assay medium were plated with RPMI (negative control), PMA (500 ng/mL; positive control), or different concentrations of BjcuL (5 and 10 μg/mL) and incubated at 37°C, in a humidified atmosphere of 5% CO 2, over a period of 2 h for COX-1 and COX-2, and a period of 24 h for iNOS determination. After incubation, PBMCs were lysed with RIPA buffer containing phosphatase and protease inhibitors (1/100, Sigma), and were homogenized. For COX-1, COX-2 and iNOS determination, total protein extracts (20 μg) were prepared, resolved by 15% SDS/PAGE and transferred onto a PVDF membrane (Hybond, Amersham Pharmacia Biotech). Immunoblotting was performed using monoclonal antibodies targeting COX-1, COX-2 (Cayman Chemical, MI, USA), or iNOS (Sigma, MO, USA). Blots were developed with 3,3′-diaminobenzidine tablets and hydrogen peroxide (Sigma-Fast).
RT-PCR
COX-1 and COX-2 gene expression was evaluated by Reverse transcription polymerase chain reaction (RT-PCR). For this assay, 1 × 10 6 / 300 μL PBMCs were incubated with RPMI (negative control), PMA (500 ng/mL; positive control), LPS (1 μg/mL; positive control), or BjcuL (5 and 10 μg/mL; experimental group) for 6 h at 37°C, in a humidified atmosphere of 5% CO 2 . Total RNA was extracted by TRIzol® LS Reagent (Ambion, Life Technologies, USA). Synthesis of cDNA was performed using a SuperScriptTM III kit (InvitrogenTM, Life Technologies, USA); a total of 500 ng of RNA was used in all experimental conditions. For the amplification of COX-1 and COX-2 specific genes via PCR, 500 ng of cDNA was added to a reaction mixture containing 1 × PCR buffer, 200 μM dNTP, 0.2 μM of gene specific primers (Invitrogen, Carlsbad, CA) (Table 1), 1.25 μL of Taq polymerase (HotMaster™, 5Prime) and water, for a final volume of 25 μL. The amplification product of GAPDH (glyceraldehyde 3-phosphate dehydrogenase) was used as cDNA control. For fragment amplification, the reaction mixtures were submitted to initial denaturation at 94°C for 5 min; followed by 30 cycles of 30 s at 94°C for denaturation; 30 cycles at 58°C (COX-2), and 30 cycles at 56°C (COX-1) for annealing; 40-60 s at 72°C for extension, depending on the amplicon size produced; and an additional extension at 72°C for 10 min. The RT-PCR products were analyzed by 1.5% agarose gel electrophoresis, stained with ethidium bromide and photo documented.
Statistical analysis
The means and standard error of the mean (S.E.M.) of all data were obtained. Data were tested for homogeneity of variances using Bartlett's test followed by Brow-Forsythe test and compared by using one-way ANOVA, followed by Tukey's test in Graph-Pad PRISM 5.0 with significance probability levels b0.05.
Results
Isolation, characterization and purification of BjucL
Fractionation of B. jararacussu crude venom on Sepharose 6B CL lactose gave two peaks (Fig. 1A) ; elution with 0.1 M Lactose preceded the second peak and the second peak showed haemagglutination activity, suggesting the presence of C-type lectin. The purity degree was determined by RP-HPLC using a C18 column (Fig. 1B) .
The apparent molecular mass determined by SDS-PAGE under nonreducing conditions showed a single spot of approximately 25 kDa. Under reducing conditions, a single band of about 15 kDa was observed (Fig. 1C) . On the other hand, the mass spectrometry procedure showed the molecular mass of isolated protein (BjcuL) to be 32,830 Da, with a second peak of about 16,332 Da corresponding to the double charge of the same protein.
Haemagglutination activity
The haemagglutinin activity was used to evaluate the presence of Ctype lectins and was carried out using human erythrocytes. The results showed that this protein exhibits high haemagglutinin activity. Moreover, the inhibition of this activity by EDTA confirms that BjcuL is a Ctype lectin (data not shown).
Effect of BjcuL on human PBMCs viability
To further investigate BjcuL's effect on PBMCs function, we isolated these cells by density gradient, according to Lacouth-Silva et al. (2015) . The purity of the isolated PBMCs was determined by flow cytometry using PE anti-human CD14 ( Supplementary Fig. 1A and B) and PerCP anti-human CD3 ( Supplementary Fig. 1C and D) . To test the ) were incubated with RPMI (negative control), PMA (500 ng/mL, positive control), or BjcuL (5 and 10 μg/ mL) in phenol red solution for 3 h at 37°C, in a humidified atmosphere of 5% CO 2 . The absorbance was measured by spectrophotometer at 620 nm. The results were expressed as μM of H 2 O 2 produced, and represent the mean ± SEM of four donors. *P b 0.05 compared to control (ANOVA). ) were incubated with RPMI (negative control; A ➔ D), PMA (500 ng/mL, positive control, E ➔ G) or BjcuL (5 and 10 μg/mL; H ➔ J and K ➔ M) in RPMI without phenol red for 3 h at 37°C, in a humidified atmosphere of 5% CO 2 . Following the addition of DCFDA (10 μM), DCF fluorescence was determined in FL1 in FACScan.
toxicity of BjcuL in isolated human PBMCs, we used the MTT assay, and investigated the effect of 96 h of BjcuL incubation. As shown in Fig. 2A , the incubation of PBMCs with RPMI (negative control) or BjcuL (5 and 10 μg/mL) did not affect cell viability at the time intervals and concentrations tested. Cell viability was also evaluated by staining at different time intervals with propidium iodide (PI) and thiazole orange (TO), and analysis by FACScan. Fig. 2B , C, D, E, F and G show that incubation of PBMCs with RPMI (negative control) or BjcuL (5 and 10 μg/mL) at different time intervals did not affect cell viability (Supplementary Fig. 2 ).
Effect of BjcuL on PBMCs proliferation
In order to verify the effect of BjcuL on PBMCs functions, the proliferation of mononuclear cells was investigated. In Fig. 3 , ConA (positive control) induced a significant proliferation of PBMCs when compared to RPMI (negative control). On the other hand, BjcuL inhibited PBMCs proliferation when used in concentrations of 5 and 10 μg/mL. These data were confirmed using CFSE. This method relies on the ability of CFSE to covalently label long-lived intracellular molecules with the highly fluorescent dye, carboxyfluorescein. Analysis of heterogeneous cell populations identified the presence and proportion of various populations of interest: Supplementary Fig. 3A and B show monocytes incubated with CFSE (negative control), and Supplementary Fig. 3C and D shows lymphocytes incubated with CFSE (positive control). Supplementary Fig. 4A , B, C, D, E and F show the different peaks that represent lymphocyte proliferation incubated with ConA (positive control). The data also shows that the proliferating cells in areas R2, R3 and R4 were CD8 + . Supplementary Fig. 5A , B, C and D, and Supplementary   Fig. 6A , B, C and D both show one peak, indicating that BjcuL (5 and 10 μg/mL) did not stimulate lymphocyte to proliferate. Moreover, it can be seen that the main populations in area R3 were mainly CD4 + and CD8 + .
Effect of BjcuL on ROS production by PBMCs
In order to investigate the interference of BjcuL in the respiratory burst and induction of superoxide anion and hydrogen peroxide by PBMCs, the cells were incubated with RPMI (negative control), PMA (positive control), or BjcuL (5 and 10 μg/mL) in the presence of NBT 0.1% for superoxide anion production, horseradish peroxidase for hydrogen peroxide production, and DCF-DA for ROS production.
As shown in Fig. 4 , BjcuL induced an increase in superoxide production as compared to the negative control (RPMI). Our results reveal that BjcuL activates human PBMCs to produce superoxide anion. Fig. 5 shows that incubation of PBMCs with PMA induced a significant increase in hydrogen peroxide production as compared to the control cells (incubated with phenol red solution). BjcuL, at concentrations of 5 and 10 μg/mL, resulted in a significant increase in hydrogen peroxide production as compared to the control cells. These findings demonstrate the ability of BjcuL to stimulate human PBMCs to produce hydrogen peroxide.
In order to identify the cell populations that BjcuL stimulates to produce ROS, the cells were subjected to immunophenotyping using CD14-PE and CD3-PerCP, incubated with DFC, and analyzed by FASCan. As shown in Fig. 6. (A ➔ D) , in the negative control, 0.23% of CD3 and 0.22% of CD14 cells produced ROS. However, panel F and G show that, in the positive control, 56.05% of CD3 and 11.27% of CD14 cells produced ROS. When PBMCs were incubated with BjcuL at concentrations of 5 and 10 μg/mL production of ROS increased by 59.9% and 64.5% respectively for CD3 cells, and by 15.57% and 12.4% respectively for CD14 cells. These results indicate that lymphocytes are the predominant cell type that produce ROS induced by BjcuL.
Effect of BjcuL on nitric oxide production by PBMCs
In order to investigate the abiltiy of BjcuL to induce the production of nitric oxide by human PBMCs, the cells were incubated with RPMI (negative control), LPS (positive control), or BjcuL (5 and 10 μg/mL). As shown in Fig. 7A , incubation of PBMCs with LPS induced a significant increase in nitric oxide production as compared to the control cells. On the other hand, BjcuL at concentrations of 5 and 10 μg/mL did not induce nitric oxide production in compariosn to the control cells, which suggests that this lectin does not stimulate PBMCs to produce nitric oxide. To investigate the effect of BjcuL on the protein expression profiles of iNOS in human PBMCs, the cells were incubated with RPMI (negative control), LPS (positive control), or BjcuL (5 and 10 μg/mL). Fig. 7C shows that BjcuL induced slight iNOS expression, but this did not differ significantly from the control cells.
To verify the ability of BjcuL to induce the release of PGE 2, and to induce COX-1 and COX-2 protein and gene expression in human PBMCs, the cells were incubated with RPMI (negative control), LPS (positive control), or BjcuL (5 and 10 μg/mL). As shown in Fig. 7B , incubation of PBMCs with LPS induced a significant liberation of PGE 2 as compared to the control cells. However, at the concentrations tested (5 and 10 μg/mL), BjcuL did not induce PGE 2 liberation as compared to the control cells; this suggests that BjcuL does not stimulate PBMCs to induce PGE 2 liberation. BjcuL did not induce an increase in either COX-1 or COX-2 protein expression as compared to the control (Fig. 7C) . The same results were obtained for COX-1 and COX-2 mRNA gene expression (Fig. 7D ) as compared to the control. These findings suggest that BjcuL does not stimulate COX protein and gene expression in PBMCs.
Discussion
The literature shows that BjcuL triggers inflammation with cellular infiltration in post capillary venules (Elifio-Esposito et al., 2007) , increases edema and vascular permeability in murine models (Panunto et al., 2006) , contributes to in vitro neutrophil activation (ElifioEsposito et al., 2011) and modulates macrophage functional activation towards an M1 state (Dias-Netipanvi et al., 2016) .
First of all, BjcuL was isolated from Bothrops jararacussu venom, as described by Gartner and Ogilvie (1984) , Guimarães-Gomes et al. (2004) and Pereira-Bittencourt et al. (1999) , using an affinity chromatography procedure with an immobilized carbohydrate matrix, which made it possible to obtain the lectin with a high degree of purity. In agreement with our results, several C-type lectins have been isolated from snake venoms of the genus Bothrops, including B. atrox (Gartner et al., 1980) , B. godmani (Lomonte et al., 1990) , B. insularis (Guimarães-Gomes et al., 2004 ), B. jararacussu (de Carvalho et al., 1998 , B. pirajai (Havt et al., 2005) , and B. leucurus (Nunes et al., 2011) , among others.
SDS-PAGE showed that, under reducing conditions, BjcuL migrated as a single protein with a molecular apparent mass corresponding to 14 kDa. In non-reducing conditions, a single band was observed (Fig.  3) , suggesting that BjcuL forms dimmers. Moreover, the molecular mass determined by mass spectrometry showed a main peak of about 32,830 Da. These results are consistent with those obtained in previous studies dealing with BjcuL isolation (Elifio-Esposito et al., 2007) , and in studies of other lectins (de Carvalho et al., 2002; Guimarães-Gomes et al., 2004; Havt et al., 2005) .
Despite the importance of lectins, we still have a limited understanding of the mechanisms of action by which BjcuL effects the function of PBMCs. Since monocytes and lymphocytes play an important role in the immune response, this study aimed to evaluate the effects of Bjcul on isolated human PBMCs. Bjcul was isolated from Bothrops jararacussu venom and its effects on cell viability were examined. Our data show that BjcuL does not affect the viability of PBMCs, which indicates that BjcuL exhibits very low toxicity on this cell type. These results are in agreement with Dias-Netipanyj et al. (2016) .
The literature shows that BjcuL has a cytotoxic effect of on human metastatic breast cancer (MDAMB-435) and human ovarian carcinoma (OVCAR-5) tumor cell lines (de Carvalho et al., 2001) . Moreover, Nolte et al. (2012) reported that BjcuL was able to exert cytotoxic effects on gastric carcinoma cells MKN45 and AGS, due to its direct interaction with specific glycans on the cell surface. These authors also observed cell viability decrease caused by the disorganization of actin filaments and apoptosis.
This study also investigated the effect of BjcuL on PBMCs proliferation. Lectins are widely known for their mitogenic actions, which may be inhibited by low concentrations of saccharide (Sharon, 2008) ; however, numerous lectins with antimitogenic actions have been described (Sharon, 2008) . The induction of proliferation seems to be associated with the binding of mitogenic lectins to the T cell receptor complex, which emits signals that lead to IL-2 synthesis. On the other hand, non-mitogenic lectins do not bind to the T cell receptor complex, nor do they bind to other accessory molecules that are essential for the activation of signal transmission. Binding to accessory molecules that do not induce the production and secretion of IL-2 may be the cause of antimitogenic action (Kilpatrick, 1999 (Kilpatrick, , 2002 . Our results indicate that BjcuL inhibits PBMCs proliferation. In addition, the analysis of heterogeneous cell populations in order to identify the presence and proportions of various populations of interest showed that the vast majority of PBMCs were lymphocytes CD4 + and CD8 + . The same results were observed by Pereira-Bittencourt et al. (1999) studying human cancer cell lines. In their study, BjcuL inhibited proliferation in eight human cancer cell lines in a dose-dependent manner. Moreover, the lectin was more potent in inhibiting the growth of renal (Caki-1 and A-498) and pancreatic (CFPAC-1) cancer cell lines with IC50 of 1-2 mM. On the other hand, BjcuL showed no effect on colon (Caco-2) and breast (MCF7) cancer cell lines. Whitacre and Cathcart (1992) showed that one way PBMCs proliferation is regulated is through oxygen free radical production, which varies depending on the type of mitogenic stimulus. Based on this, we conducted experiments to verify the effect of BjcuL on superoxide anion production by PBMCs. Our results show, for the first time, that BjcuL is able to stimulate PBMCs production of superoxide anion. This may explain the inhibition of PBMCs proliferation that is induced by lectin.
This study also investigated BjcuL induced hydrogen peroxide production in PBMCs. Superoxide anion inside the cells is converted to hydrogen peroxide, mainly by spontaneous dismutation. Hydrogen peroxide can form the highly reactive radical, hydroxyl (Babior, 1984; Fujiwara and Kobayashi, 2005; Rutkowski et al., 2007; Manea, 2010) . Our data shows that the BjcuL induced PBMCs to produce hydrogen peroxide, which is in agreement with Dias-Netipanvi et al. (2016) . These authors showed that BjcuL stimulated the differentiated monocyte-derived macrophage U937 cells to produce hydrogen peroxide. In addition, our results demonstrate that BjcuL is capable of activating leukocytes that trigger oxidative metabolism by converting molecular oxygen into reactive oxygen intermediates, a process called respiratory burst.
In addition to the reactive oxygen species, superoxide anion and hydrogen peroxide, reactive nitrogen species were also investigated. Nitric oxide (NO) is a radical generated at relatively high and sustained levels by the inducible forms of NO synthase (iNOS or NOS-2).
The literature shows that NO is antiproliferative for T lymphocytes and that this effect is exerted particularly by the action of NO donors and by the action on regulation of cytokine expression, which is dependent on exposure time (Macphail et al., 2003) . Based on this knowledge, the nitrite was measured in the supernatant of PBMCs in order to assess the effect of BjcuL on the production of NO by PBMCs. Our results show that BjcuL is unable to stimulate PBMC to release NO, nor is it able to induce iNOS protein expression.
The literature documents a complex interplay between NOS and COX pathways. This complexity is apparent in the products of NOS and COX systems that are able to mediate the regulation and expression of inducible forms (NOS-2 and COX-2). Mediation occurs via the interplay of intracellular crosstalk between signaling pathways stimulated by products of NOS and COX (which contribute significantly to the complexity of cellular signaling), and via the reciprocal modulation of cyclooxygenase activity by nitric oxide and of NOS activity by prostaglandins (Sorokin, 2016) .
To this end, we investigated the effect of BjcuL on the production of PGE 2 by PBMCs, and our results show that the lectin does not stimulate the cells to produce PGE 2, nor does it stimulate COX-1 and COX-2 mRNA and protein expression. This data, combined with the NO data, helps explain, at least in part, the effect of BjcuL on PBMCs. Moreover, another study has indicated that nitric oxide can modulate prostaglandin synthesis, which includes the direct inactivation of prostaglandin I synthase by peroxynitrite (Sorokin, 2016) , a product of superoxide reaction with nitric oxide (Robbins and Grisham, 1997; Rutkowski et al., 2007; Plekhova and Somova, 2012) . The data presented herein make it possible to assert that BjcuL inhibits PBMCs proliferation via a mechanism that involves oxygen but does not involve nitrogen reactive intermediates or PGE 2 induced by the lectin.
The results obtained in this study highlight the effect that BjcuL has on the immunomodulatory activity of PBMCs, as observed by DiasNetipanvi et al. (2016) . Further studies are needed to confirm the immunomodulatory effect of BjcuL, to elucidate the molecular mechanisms of action responsible for its effects and to determine its potential application as an immunopharmacological and biotechnological tool.
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.tiv.2017.02.003. 
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